Sixth child dies from congenital syphilis in northern Australia

From the BMJ.com, 20 March 2018: Australia has recorded its sixth infant death from congenital syphilis, in a seven year long epidemic that has disproportionately impacted remote Aboriginal communities. The outbreak began in January 2011 in northwest Queensland, and over the following two years spread across to the Northern Territory, then to Western Australia, and Continue reading Sixth child dies from congenital syphilis in northern Australia

Interferon-free HCV-1 regimen scored high in patients co-infected with HIV

From Internal Medicine News, 24 July 2014: MELBOURNE – A regimen of ABT-450 coformulated with ritonavir, ombitasvir, and dasabuvir, plus ribavirin, resulted in high rates of sustained virologic response in hepatitis C patients co-infected with HIV. Further, the treatment approach did not have a negative effect on HIV viral load. Data from the open-label study, Continue reading Interferon-free HCV-1 regimen scored high in patients co-infected with HIV

Tuberculosis, malaria, and HIV in decline since Millennium Declaration

From  Skin and Allergy News, 21 July 2014: Tuberculosis, HIV, and malaria incidence and mortality have all declined significantly since the formulation of Millennium Development Goal 6 in 2000, which focused global attention on these three diseases and made them a priority. Analysis of data from the Global Burden of Disease Study 2013 showed that Continue reading Tuberculosis, malaria, and HIV in decline since Millennium Declaration

Sofosbuvir achieves sustained response in patients with hepatitis C and HIV

From Skin and Allergy News, 21 July 2014: Treatment with the interferon-free oral nucleotide analog sofosbuvir plus ribavirin achieved high rates of sustained virologic response in patients with HIV coinfected with hepatitis C, according to data from an open-label phase III study. Researchers observed an 82% response rate among treatment-naive patients coinfected with hepatitis C Continue reading Sofosbuvir achieves sustained response in patients with hepatitis C and HIV

Stem cell transplantation achieved temporary HIV remission

From Family Practice News, 21 July 2014: Allogeneic hematopoietic stem cell transplantation from HIV-naive individuals to HIV-1–positive individuals may achieve temporary antiretroviral-free remission of infection and loss of detectable HIV-1, a study showed. Two men with chronic HIV-1 infection received allogeneic hematopoietic stem cell transplants (HSCTs) from susceptible donors to treat Hodgkin’s and non-Hodgkin’s lymphoma, Continue reading Stem cell transplantation achieved temporary HIV remission

International AIDS conference pays tribute to colleagues on flight MH17

From Family Practice News, 21 July 2014: MELBOURNE – Speakers at the opening plenary of the 20th International AIDS Conference struggled with their emotions as they paid tribute to colleagues – including former International AIDS Society President Dr. Joep Lange – who were killed when Malaysian Airlines flight MH17 crashed in Ukraine. Dr. Lange was Continue reading International AIDS conference pays tribute to colleagues on flight MH17

T cell turnoff

From Scientific American, December 2007: HIV is devastating because it attacks and destroys the body’s defense system against pathogens, leaving patients fatally exposed. So what would possess scientists to treat HIV-positive patients with drugs that suppress the immune system? Such therapy may in fact offer a new approach in the battle against AIDS. An unexpected Continue reading T cell turnoff